Without a Prescription
Gliclazide is prescribed together with diet and exercise to reduce blood glucose in patients with type 2 diabetes.
Gliclazide is prescribed in the treatment of type 2 diabetes if it is combined with:
- Insulin therapy;
- Diet and;
Among the symptoms of overdose with Gliclazide are:
- Cold sweats;
- Sometimes even coma;
The symptoms are:
- Lip / tongue / face swelling;
- Difficulty in breathing;
- Closing of the throat;
If your blood sugar drops because of your treatment with Gliclazide you will probably start having:
- Cold skin;
- Cold sweats;
- Difficulty in focusing;
If your blood sugar level rises you will probably:
- You will urinate more often;
- Feel hungrier;
Side effects include:
Skin rashes can occur and cause:
- Adiffuse measles-like rash;
Rare but serious side effects include:
- Alow sodium concentration;
Gliclazide may also cause hypoglycemia.
The risk of hypoglycemia increases when Gliclazide is combined with other glucose reducing agents.
If you are taking aspirin or other salicylates such as :
- Bismuth subsalicylate;
- Choline salicylate;
- Magnesium salicylate;
- Monoamine oxidase inhibitor;
- Nonsteroidal anti-inflammatory drug;
- Sulfa-based drug;
Gliclazide could also be affected by other drugs such as:
- Steroid medicine like prednisone;
- Phenothiazine like chlorpromazine;
- Diuretic like hydrochlorothiazide;
- Beta-blocker like propranolol;
Tablets: 5 milligrams,
Tablets: 10 milligrams,
Tablets Extended Release (XR): 2.5 milligrams,
Tablets Extended Release (XR): 5 milligrams,
Tablets Extended Release (XR): 10 milligrams.
The usual starting dose when using immediate release tablets is 5 milligrams administered 30 minutes before a meal. The maximum dose is 40 milligrams daily. Doses higher than 15 milligrams per day should be divided.
The starting dose when using extended-release tablets is 5 milligrams daily up to a maximum dose of 20 milligrams daily. Patients using immediate release tablets may be converted to the nearest equivalent extended-release dose.